Broegelmann Research Laboratory
Initiated in 1957 and co-localized and integrated with the Department of Clinical Science (Klinisk Institutt 2), BRL is internationally recognised as one of the leading groups on experimental, clinical and genetic studies of Sjögren's syndrome. BRL is closely associated with the Scandinavian Journal of Immunology, Bergen Research School in Inflammation and the Bergen Flow Cytometry Core Facility.
The group is lead by Professor Helena Erlandsson Harris, the Broegelmann chair of translation immunology and head of the Immunology and Rheumatology group.
BRL is composed of several principal investigators (PIs), with current areas of research including translational studies in autoimmunity, functional genomics and genetic basis of autoimmune exocrinopathy, dendritic cells in immunotherapy, host microbe interactions, and hyperinflammatory primary immunodeficiency syndrome.
BRL is multinational research environment with group leaders originating throughout Europe and lab members throughout the world.